Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support
Authors:
- 21 October 2019
- journal article
- research article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 16 (5) , 168-179
Abstract
The purpose of this review is to synthesize and summarize recent developments in the care of patients with end-stage heart failure being managed with a left ventricular assist device (LVAD) as destination therapy.Keywords
This publication has 112 references indexed in Scilit:
- Predicting Right Ventricular Failure in the Modern, Continuous Flow Left Ventricular Assist Device EraThe Annals of Thoracic Surgery, 2013
- Thrombolysis for Suspected Intrapump Thrombosis in Patients With Continuous Flow Centrifugal Left Ventricular Assist DeviceArtificial Organs, 2013
- Axial and centrifugal continuous-flow rotary pumps: A translation from pump mechanics to clinical practiceThe Journal of Heart and Lung Transplantation, 2013
- Right heart failure after left ventricular assist device implantationCurrent Opinion in Cardiology, 2012
- The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported PatientsCirculation: Heart Failure, 2010
- Increased Incidence of Gastrointestinal Bleeding Following Implantation of the HeartMate II LVADJournal of Cardiac Surgery, 2010
- The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incisionAmerican Heart Journal, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- The Seattle Heart Failure ModelCirculation, 2006
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001